Skip to main content
. 2022 Mar 24;14(7):1643. doi: 10.3390/cancers14071643

Table 2.

Patients’ characteristics divided by RT boost’s groups.

Patient’s Characteristics Boost Yes Boost No p Value §
Sex 0.368
Male 46 (56.1%) 59 (62.8%)
Female 36 (43.9%) 35 (37.2%)
Age 0.760
≤50 years 9 (11%) 9 (9.6%)
<50 years 73 (89%) 85 (90.4%)
cT 0.644
2 1 (1.2%) 2 (2.1%)
3 49 (59.8%) 50 (53.2%)
4 32 (39%) 42 (44.7%)
cN 0.577
1 19 (23.2%) 21 (22.3%)
2 63 (76.8%) 73 (77.7%)
EMVI 0.001
+ 9 (11%) 5 (5.3%)
71 (86.6%) 69 (73.4%)
N/A 2 (2.4%) 20 (21.3%)
Mucinous 0.003
Yes 4 (4.9%) 6 (6.4%)
No 76 (92.7%) 71 (75.5%)
N/A 2 (2.4%) 17 (18.1%)
MRF 0.834
+ 40 (48.8%) 48 (51.1%)
38 (46.3%) 43 (45.7%)
N/A 4 (4.9%) 3 (3.2%)
Surgery Type 0.101
Anterior Resection (AR) 53 (64.6%) 56 (59.6%)
Abdominoperineal Resection (APR) 20 (24.4%) 20 (21.3%)
Hartmann 1 (1.2%) 5 (5.3%)
Local Excision 7 (8.5%) 5 (5.3%)
Colostomy 1 (1.2%) 8 (8.5%)
RT dose on T <0.001
55 Gy 78 (95.1%) 71 (75.5%)
<55 Gy 4 (4.9%) 23 (24.5%)
RT dose on LPLN 8.45
55 Gy 78 (95.1%) 0 (0%)
<55 Gy 4 (4.9%) 94 (100%)

§ χ2 test.